Jean-Sébastien Cleiftie
Direttore/Membro del Consiglio presso BioVex, Inc.
Posizioni attive di Jean-Sébastien Cleiftie
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Jean-Sébastien Cleiftie
Precedenti posizioni note di Jean-Sébastien Cleiftie
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Corporate Officer/Principal | 27/10/2016 | 01/11/2021 |
| SANOFI | Corporate Officer/Principal | 01/10/2010 | 01/08/2016 |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Direttore/Membro del Consiglio | 15/10/2009 | 24/01/2013 |
PC Associés SAS
 PC Associés SAS Investment ManagersFinance IPSA SA (IPSA), a subsidiary of ACG SA, is a venture capital firm headquartered in Paris. Formerly known as Innoven Partenaires SA, the firm was founded in 1997. | Analista di Private Equity | 01/01/2004 | 01/12/2010 |
Innoven Partners
 Innoven Partners Financial ConglomeratesFinance Innoven Partners is an investment fund. The private company is based in Paris, France. | Corporate Officer/Principal | 01/02/2004 | 01/10/2010 |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | - | 31/08/2010 |
| KIORA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | - | - |
Formazione di Jean-Sébastien Cleiftie
| Cornell University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Francia | 6 |
| Stati Uniti | 5 |
| Regno Unito | 2 |
Posizioni
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Private Equity Analyst | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
| Finance | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SANOFI | Health Technology |
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
PC Associés SAS
PC Associés SAS Investment ManagersFinance IPSA SA (IPSA), a subsidiary of ACG SA, is a venture capital firm headquartered in Paris. Formerly known as Innoven Partenaires SA, the firm was founded in 1997. | Finance |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Health Technology |
| Université de Paris 5 René Descartes | Consumer Services |
Innoven Partners
Innoven Partners Financial ConglomeratesFinance Innoven Partners is an investment fund. The private company is based in Paris, France. | Finance |
